跳至主要内容
临床试验/CTRI/2024/08/072273
CTRI/2024/08/072273尚未招募不适用

A study of oral mucositis, pain, xerostomia and quality of life in patients with oral cavity and oropharyngeal cancers undergoing radiotherapy

Sri Venkateswara Institute of Medical Sciences Tirupati1 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2024年8月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
67
试验地点
1
主要终点
To assess the toxicities in patients of head and neck cancer undergoing radiotherapy

研究概览

简要总结

AIM AND OBJECTIVES

AIM: To study the acute toxicities such as pain, mucositis  and late sequelae of radiotherapy such as xerostomia in patients receiving concurrent chemo radiotherapy in Head and Neck cancer and also to assess quality of life in same patients.

OBJECTIVES:

PRIMARY OBJECTIVE:

To assess the toxicities in patients of head and neck cancer undergoing radiotherapy (i pain, ii.oral mucositis, iii. Xerostomia.)

SECONDARY OBJECTIVE:

To assess the quality of life.

SAMPLE SIZE:

The calculated sample size is 67.

INCLUSION AND EXCLUSION CRITERIA

INCLUSION CRITERIA:

·   1. Carcinoma of head and neck including oral cavity, oropharynx undergoing IMRT, VMAT and concurrent chemotherapy .

·     2. Patients of age group between 18-65 yrs.

·     3. Patient with ECOG 0-2.

·   4. Patients willing to sign an informed consent.

EXCLUSION CRITERIA:

·     1. Patients with  previous history of radiation to head and neck.

·      2. Patients with known distant metastasis.

·      3. Patients with ECOG 3-4

    1. Pregnant women and lactating mothers

PATIENT EVALUATION:

All patients will be  evaluated before RT ,weekly during the course of treatment  and monthly for 3 months after radiotherapy for the acute toxicities(mucositis, pain, xerostomia, quality of life) and 6 months for late toxicities (xerostomia , quality of life).

Assessment of pain will be done by using Visual Analogue Scale.

Assessment of mucositis and xerostomia and grading will be done according to RTOG-Early and Late Radiation Morbidity scoring scheme.

Assessment of Quality of life using EORTC QLQ H&N 35 Questionnaire.

Follow up of the patients was advised monthly for 3 months and 2 monthly for 6 months.

STATISTICAL ANALYSIS:

Data will be collected in the study proforma , entered in Microsoft Excel(Windows 11;Version 2021)and analyses will be done using the Statistical Package for Social Sciences(SPSS)for Windows software (version 26.0;SPSS Inc, Chicago) .Continuous variables will be presented in the form of mean, standard deviation, range, and categorical data will be presented in the form of number and percentage. Chi-Square test or Fischers  exact test  will be used for qualitative parameters. Student’s t-test will be used for quantitative variables. P value  <0.05 will be considered statistically significant

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Carcinoma of head and neck including oral cavity, oropharynx undergoing IMRT, VMAT and concurrent chemotherapy .
  • 2.Patients of age group between 18-65 yrs.
  • 3.Patient with ECOG 0-
  • 4.Patients willing to sign an informed consent.

排除标准

  • Patients with previous history of radiation to head and neck.
  • Patients with known distant metastasis.
  • Patients with ECOG 3-4
  • Pregnant women and lactating mothers.

结局指标

主要结局

To assess the toxicities in patients of head and neck cancer undergoing radiotherapy

时间窗: From Day 1 of treatment to 6 months after treatment completion.

1) pain,

时间窗: From Day 1 of treatment to 6 months after treatment completion.

2) oral mucositis

时间窗: From Day 1 of treatment to 6 months after treatment completion.

3) Xerostomia

时间窗: From Day 1 of treatment to 6 months after treatment completion.

次要结局

  • To assess the quality of life(From Day 1 of treatment to 6 months after treatment completion.)

研究者

发起方
Sri Venkateswara Institute of Medical Sciences Tirupati
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr M Likhitha

Sri Venkateswara Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验